. 1982 Feb;92(2):157-9.

[Contents of cysteinyldopa isomers and DOPA in lesions of malignant melanoma (author's transl)]

[Article in Japanese]

[Article in Japanese]

T Morishima et al. Nihon Hifuka Gakkai Zasshi. 1982 Feb.

. 1982 Feb;92(2):157-9.

No abstract available

Similar articles

Cysteinyldopa isomers and dopa in lesions and urine of Japanese patients with malignant melanoma.
Morishima T, Tatsumi F, Fukada E, Saito M, Fujita M, Nagashima N, Hanawa S. Morishima T, et al. Arch Dermatol Res. 1983;275(2):76-9. doi: 10.1007/BF00412878. Arch Dermatol Res. 1983. PMID: 6409012
[Diagnosis of amelanotic malignant melanoma by means of the fluorescence method (Falck & Hillarp) and determination of 5-S-cysteinyldopa in the lesions].
Morishima T, Fukada E, Nagashima N. Morishima T, et al. Nihon Hifuka Gakkai Zasshi. 1983 Jan;93(1):51-4. Nihon Hifuka Gakkai Zasshi. 1983. PMID: 6408288 Japanese. No abstract available.
Intracellular distribution of dopa and 5-S-cysteinyldopa in Harding-Passey melanoma.
Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E. Agrup G, et al. Acta Derm Venereol. 1977;57(4):313-5. Acta Derm Venereol. 1977. PMID: 70922
Melanin-related metabolites as markers of melanoma: a review.
Ito S. Ito S. J Dermatol. 1992 Nov;19(11):802-5. doi: 10.1111/j.1346-8138.1992.tb03785.x. J Dermatol. 1992. PMID: 1293166 Review. No abstract available.
Melanin chemistry and melanin precursors in melanoma.
Ito S, Wakamatsu K. Ito S, et al. J Invest Dermatol. 1989 May;92(5 Suppl):261S-265S. doi: 10.1111/1523-1747.ep13076587. J Invest Dermatol. 1989. PMID: 2654299 Review. No abstract available.